BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 32437911)

  • 1. Development of embryonic and adult leukemia mouse models driven by MLL-ENL translocation.
    Sinha R; Porcheri C; d'Altri T; González J; Ruiz-Herguido C; Rabbitts T; Espinosa L; Bigas A
    Exp Hematol; 2020 May; 85():13-19. PubMed ID: 32437911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias.
    Young K; Loberg MA; Eudy E; Schwartz LS; Mujica KD; Trowbridge JJ
    Exp Hematol; 2020 Sep; 89():61-67.e3. PubMed ID: 32768438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program.
    Rice S; Jackson T; Crump NT; Fordham N; Elliott N; O'Byrne S; Fanego MDML; Addy D; Crabb T; Dryden C; Inglott S; Ladon D; Wright G; Bartram J; Ancliff P; Mead AJ; Halsey C; Roberts I; Milne TA; Roy A
    Nat Commun; 2021 Nov; 12(1):6905. PubMed ID: 34824279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A complex interplay of intra- and extracellular factors regulates the outcome of fetal- and adult-derived MLL-rearranged leukemia.
    Jassinskaja M; Ghosh S; Watral J; Davoudi M; Claesson Stern M; Daher U; Eldeeb M; Zhang Q; Bryder D; Hansson J
    Leukemia; 2024 May; 38(5):1115-1130. PubMed ID: 38555405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid transformation by
    Wesolowski R; Kowenz-Leutz E; Zimmermann K; Dörr D; Hofstätter M; Slany RK; Mildner A; Leutz A
    Life Sci Alliance; 2021 Jan; 4(1):. PubMed ID: 33144337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Property Focused Structure-Based Optimization of Small Molecule Inhibitors of the Protein-Protein Interaction between Menin and Mixed Lineage Leukemia (MLL).
    Borkin D; Pollock J; Kempinska K; Purohit T; Li X; Wen B; Zhao T; Miao H; Shukla S; He M; Sun D; Cierpicki T; Grembecka J
    J Med Chem; 2016 Feb; 59(3):892-913. PubMed ID: 26744767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1.
    Barbosa K; Deshpande A; Chen BR; Ghosh A; Sun Y; Dutta S; Weetall M; Dixon J; Armstrong SA; Bohlander SK; Deshpande AJ
    Exp Hematol; 2019 Jun; 74():42-51.e3. PubMed ID: 31022428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute lymphoblastic leukemia with inv(11)(q21q23.3)/KMT2A::MAML2 fusion gene progressed to acute myeloid leukemia: a case report].
    Zhang Y; Ni JB; Zhang QJ; Hui S; Wang CF; Wang T
    Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):196. PubMed ID: 38604799
    [No Abstract]   [Full Text] [Related]  

  • 9. Genome editing-induced t(4;11) chromosomal translocations model B cell precursor acute lymphoblastic leukemias with KMT2A-AFF1 fusion.
    Pan F; Sarno J; Jeong J; Yang X; Jager A; Gruber TA; Davis KL; Cleary ML
    J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 37917159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery, Structure-Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein-Protein Interactions between AF9/ENL and AF4 or DOT1L.
    Li X; Wu X; Nie S; Zhao J; Yao Y; Wu F; Mishra CB; Ashraf-Uz-Zaman M; Moku BK; Song Y
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rewiring the Epigenetic Networks in
    Chan AKN; Chen CW
    Front Cell Dev Biol; 2019; 7():81. PubMed ID: 31157223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL-mediated leukemia.
    Nakamura A; Masuya M; Shinmei M; Tawara I; Nosaka T; Ono R
    Blood Adv; 2024 Mar; 8(9):2193-206. PubMed ID: 38452334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the fetal origin of MLL-AF4 infant leukemia highlights specific fatty acid requirements.
    Symeonidou V; Jakobczyk H; Bashanfer S; Malouf C; Fotopoulou F; Kotecha RS; Anderson RA; Finch AJ; Ottersbach K
    Cell Rep; 2021 Oct; 37(4):109900. PubMed ID: 34706236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Layered immunity and layered leukemogenicity: Developmentally restricted mechanisms of pediatric leukemia initiation.
    Mendoza-Castrejon J; Magee JA
    Immunol Rev; 2023 May; 315(1):197-215. PubMed ID: 36588481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Acute Lymphoblastic Leukemias, Mixed-Phenotype Acute Leukemias, Myeloid/Lymphoid Neoplasms With Eosinophilia, Dendritic/Histiocytic Neoplasms, and Genetic Tumor Syndromes.
    Choi JK; Xiao W; Chen X; Loghavi S; Elenitoba-Johnson KS; Naresh KN; Medeiros LJ; Czader M;
    Mod Pathol; 2024 Mar; 37(5):100466. PubMed ID: 38460674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable
    Michino M; Khan TA; Miller MW; Fukase Y; Vendome J; Adura C; Glickman JF; Liu Y; Wan L; Allis CD; Stamford AW; Meinke PT; Renzetti LM; Kargman S; Liverton NJ; Huggins DJ
    ACS Med Chem Lett; 2024 Apr; 15(4):524-532. PubMed ID: 38628784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic human leukemia models: towards precision medicine.
    Cellot S; Wilhelm BT; Barabé F
    Oncotarget; 2017 Nov; 8(57):96480-96481. PubMed ID: 29228546
    [No Abstract]   [Full Text] [Related]  

  • 18. The evolution of relapse of adult T cell acute lymphoblastic leukemia.
    Sentís I; Gonzalez S; Genescà E; García-Hernández V; Muiños F; Gonzalez C; López-Arribillaga E; Gonzalez J; Fernandez-Ibarrondo L; Mularoni L; Espinosa L; Bellosillo B; Ribera JM; Bigas A; Gonzalez-Perez A; Lopez-Bigas N
    Genome Biol; 2020 Nov; 21(1):284. PubMed ID: 33225950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploitable metabolic dependencies in MLL-ENL-induced leukemia.
    Garcia-Cuellar MP; Lawlor J; Böttcher M; Mougiakakos D; Metzler M; Slany RK
    Blood Adv; 2020 Aug; 4(15):3626-3638. PubMed ID: 32766858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency.
    Kozyra EJ; Pastor VB; Lefkopoulos S; Sahoo SS; Busch H; Voss RK; Erlacher M; Lebrecht D; Szvetnik EA; Hirabayashi S; Pasaulienė R; Pedace L; Tartaglia M; Klemann C; Metzger P; Boerries M; Catala A; Hasle H; de Haas V; Kállay K; Masetti R; De Moerloose B; Dworzak M; Schmugge M; Smith O; Starý J; Mejstrikova E; Ussowicz M; Morris E; Singh P; Collin M; Derecka M; Göhring G; Flotho C; Strahm B; Locatelli F; Niemeyer CM; Trompouki E; Wlodarski MW;
    Leukemia; 2020 Oct; 34(10):2673-2687. PubMed ID: 32555368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.